AJP - Renal Physiology, Vol 265, Issue 5 651-F659, Copyright © 1993 by American Physiological Society

ARTICLES

Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II

R. J. Barrett and D. A. Droppleman
Department of Pharmacology, Whitby Research, Richmond, Virginia 23261.

Renal vasoconstrictor responses to the adenosine A1 agonist N6-cyclopentyladenosine (CPA) were compared in the in situ autoperfused rat kidney to responses evoked by angiotensin II (ANG II), endothelin-1 (ET-1), arginine vasopressin (AVP), carbocyclic thromboxane A2 (CTxA2), phenylephrine (PE), and 5-hydroxytryptamine (5-HT). On the basis of their ED50 values (dose of agonist, in mass units, that produced 50% of maximal response to that agonist), the order of vasoconstrictor potency was ANG II > or = AVP > ET-1 > CPA > 5-HT > or = PE > CTxA2. Dose-response curves to CPA were shallower and maximal responses were weaker than those produced by the other agonists. Maximal responses, the log ED50, and the slope of the dose-response curve to CPA were markedly potentiated in the presence of the nitric oxide (NO) synthase inhibitor N omega-nitro-L-arginine methyl ester (L-NAME). Selective antagonism of A1 receptors increased renal blood flow and markedly attenuated CPA-induced renal vasoconstriction in the absence or presence of L-NAME but had no effect on the maximal responses to ANG II. Conversely, AT1 receptor antagonism attenuated renal vasoconstriction produced by ANG II but had little effect on the produced by CPA. These results suggest that endogenous NO modulates renal vasoconstriction produced by A1 receptor stimulation and provide evidence against an interaction between renovascular adenosine A1 and angiotensin AT1 receptors.

This article has been cited by other articles:

				V. Vallon, B. Muhlbauer, and H. Osswald Adenosine and kidney function. Physiol Rev, July 1, 2006; 86(3): 901 - 940. [Abstract] [Full Text] [PDF]

				P. B. Hansen and J. Schnermann Vasoconstrictor and vasodilator effects of adenosine in the kidney Am J Physiol Renal Physiol, October 1, 2003; 285(4): F590 - F599. [Abstract] [Full Text] [PDF]

				E. W. Inscho P2 receptors in regulation of renal microvascular function Am J Physiol Renal Physiol, June 1, 2001; 280(6): F927 - F944. [Abstract] [Full Text] [PDF]

				E. P. Silldorff and T. L. Pallone Adenosine signaling in outer medullary descending vasa recta Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R854 - R861. [Abstract] [Full Text] [PDF]

				G. C. Schoonmaker, R. W. Fallet, and P. K. Carmines Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus Am J Physiol Renal Physiol, February 1, 2000; 278(2): F302 - F309. [Abstract] [Full Text] [PDF]

				L. Tang, M. Parker, Q. Fei, and R. Loutzenhiser Afferent arteriolar adenosine A2a receptors are coupled to KATP in in vitro perfused hydronephrotic rat kidney Am J Physiol Renal Physiol, December 1, 1999; 277(6): F926 - F933. [Abstract] [Full Text] [PDF]

				M. FRANCO, E. TAPIA, F. MARTÍNEZ, MA. E. DAVILA, J. I. GRIMALDO, K. MEDINA, and J. HERRERA-ACOSTA Adenosine Regulates Renal Nitric Oxide Production in Hypothyroid Rats J. Am. Soc. Nephrol., August 1, 1999; 10(8): 1681 - 1688. [Abstract] [Full Text]

				V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF]